Genetic Linkage Studies of Stuttering

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3044 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-07-22

Study Completion Date

2019-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stuttering is an abnormality in speech that affects the rhythm of speech. People who stutter know what they wish to say, but at the time are unable to say it because of involuntary repetition, unnecessary lengthening (prolongation), or early stopping (cessation). Stuttering is characterized by repetitions or prolongation of the first syllable, or silent prolongations, sometimes known as blocks.

Researcher intend on studying the genetic basis for stuttering. The goal of the study is to find the genes that help cause stuttering and determine regions of the human genetic make-up (genome) that are linked to stuttering.. To do this researchers will study the patterns of inheritance in families who have had members who stutter.

The study has two objectives.

The first objective is to develop a large collection of DNA samples from individuals in stuttering families, that will include both members that stutter and who do not stutter.

The second objective of the study will be to find out the basic combination of genes (genotype) making up all of the participants DNA. Once this is completed researchers hope to map out and find areas or regions of DNA that are linked to stuttering.

Genetic linkage is the initial step in positional cloning, and the cloning of genes which predispose individuals to stuttering is a long term goal of this research study.\<TAB\>

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic Factors Related to Stuttering

NCT00001602

Stuttering

COMPLETED

Characteristics of Episodic Ataxia Syndrome

NCT00266760

Episodic Ataxia Syndrome Cerebellar Diseases

COMPLETED

Study of Inherited Neurological Disorders

NCT00004568

Motor Neuron Disease Muscular Disease Muscular Dystrophy +1 more

RECRUITING

Genetics of Motor Learning

NCT01105845

Parkinson s Disease Dystonic Disorders Focal Dystonia +1 more

TERMINATED

Genetic and Physical Characteristics of Rett Syndrome

NCT00299312

Rett Syndrome MECP2 Duplication Disorder Rett-related Disorder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A primary goal of this study is to ascertain regions of the human genome which show genetic linkage to stuttering. Genetic linkage will be determined by first obtaining genomic DNA from both affected and unaffected adults and children from families containing pairs of individuals who stutter as adults. Individuals who stutter from genetically isolated populations will also be sampled. Phenotype will be assigned by a speech-language pathologist, and DNA samples will be obtained from affected and unaffected family members from 2 cc. of saliva or from 20 cc. of blood. These DNA samples will then be genotyped using markers distributed across the human genome. The genotypic information analyzed to determine which markers or variants show linkage to stuttering. The initial goal of this study is to identify specific genetic variants, which predispose individuals to stuttering. No genetic information will be provided back to participants. A secondary goal of the study will be to perform broad clinical evaluations of the individuals found to have mutations that cause stuttering. These will take place at the NIH Clinical Center and will include standard procedures including history and physical, neurological exam, audiological exam, ophthalmologic exam, electromyographic (EMG) exam, electroencephalography (EEG), X-rays, speech evaluation, and brain imaging including MRI and fMRI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stuttering

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Subjects with a family history of stuttering

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals age 8 and older.
* Individuals age 6-8 with a family history of persistent stuttering
* Have stuttering that persists for a period of 6 months or more or are a family member of that person
* For the Phase 2 imaging studies, we will be enrolling up to 25 healthy volunteers to be controls

Exclusion Criteria

* Stuttering only as a young child (before age 5) with no other family members who stutter
* Inability to provide informed consent or have a parent/guardian to provide consent
* Development of stuttering following trauma to the central nervous system.
* Chronic medical conditions that prevent informed consent or clear evaluation of stuttering, including stroke, dementia, and degenerative neurological disease.
* Inability to travel to the NIH Clinical Center for Phase 2

Minimum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No